Mein Warenkorb

CD58

CD58 Molekülinformation

Englischer NameLymphocyte function-associated antigen 3Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel1Target-AliasCD58 Antigens,Surface glycoprotein LFA-3,LFA3,LFA-3,CD58 Molecule,CD58 Antigen,CD58,CD58 Antigen, (Lymphocyte Function-Associated Antigen 3)
Höchste Forschungs- und EntwicklungsphaseClinical
Englischer NameLymphocyte function-associated antigen 3
Target-AliasCD58 Antigens,Surface glycoprotein LFA-3,LFA3,LFA-3,CD58 Molecule,CD58 Antigen,CD58,CD58 Antigen, (Lymphocyte Function-Associated Antigen 3)
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel1
Höchste Forschungs- und EntwicklungsphaseClinical

CD58 Produktliste

  • Attribut

    Protein (2)

  • Produktbibliothek

    Online (2)

  • Spezies

    Human (2)

  • Etikett

    His Tag (1)Fc Tag (1)

  • Marker

    Unconjugated (2)

ProduktnummerSpeziesExpressionssystemProduktbeschreibungProteinstrukturReinheitEigenschaftenVorbestellen/Bestellen
LF3-H5225
Human
HEK293
Human CD58 / LFA-3 Protein, His Tag
In den Warenkorb legen
LF3-H5256
Human
HEK293
Human CD58 / LFA-3 Protein, Fc Tag
In den Warenkorb legen
Gesamtmenge2
  • 1

CD58 Molekülhintergrund

CD antigen CD58 is also known as Lymphocyte function-associated antigen 3 (LFA-3). CD58 is a cell adhesion molecule expressed on Antigen Presenting Cells (APC), particularly macrophages. CD58 /LFA3 is ligand of the T-lymphocyte CD2 glycoprotein, which binds to CD2 (LFA-2) [3] on T cells and is important in strengthening the adhesion between the T cells and Professional Antigen Presenting Cells. In addition, the LFA-3/CD2 interaction may prime response by both the CD2+ and LFA-3+ cells. Polymorphisms in the CD58 gene are associated with increased risk for multiple sclerosis.

CD58 Molekülalias

CD58,LFA3,Ag3

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
Recombinant human LFA-3-antibody fusion protein (Taizhou Mabtech Pharmaceutical)ClinicalTaizhou Maibo Taike Biotechnology Co LtdPsoriasis
Details
  • Molekülinformation
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns